NASDAQ:SNMX - Senomyx Stock Price, Forecast & News Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Senomyx Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Compare Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume151,720 shsMarket Capitalization$72.03 millionP/E RatioN/ADividend YieldN/ABeta1.33 ProfileEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Senomyx, Inc discovers, develops, and commercializes flavor ingredients and natural high intensity sweeteners primarily for the packaged food, beverage, and ingredient supply industries in the United States. The company develops and/or commercializes sweet, savory and salt flavor ingredients, bitter blockers and cooling agents. It sells various flavor ingredients directly to flavor companies. Read More… Industry, Sector and Symbol Stock Exchange NASDAQ Industry Commercial physical research Sub-IndustryN/A SectorConsumer Staples Current SymbolNASDAQ:SNMX Previous Symbol CUSIPN/A CIK1123979 Webhttp://www.senomyx.com/ Phone858-646-8300Debt Debt-to-Equity RatioN/A Current Ratio4.35 Quick Ratio3.92Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$29.32 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$0.39 per share Price / BookN/AProfitability EPS (Most Recent Fiscal Year)($0.03) Net Income$-1,260,000.00 Net Margins-9.11% Return on Equity-15.80% Return on Assets-10.48%Miscellaneous EmployeesN/A Outstanding Shares48,340,000Market Cap$72.03 million Next Earnings DateN/A OptionableOptionable Receive SNMX News and Ratings via Email Sign-up to receive the latest news and ratings for SNMX and its competitors with MarketBeat's FREE daily newsletter. Senomyx (NASDAQ:SNMX) Frequently Asked Questions What is Senomyx's stock symbol? Senomyx trades on the NASDAQ under the ticker symbol "SNMX." How were Senomyx's earnings last quarter? Senomyx Inc. (NASDAQ:SNMX) posted its earnings results on Thursday, August, 2nd. The specialty chemicals company reported ($0.08) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.09) by $0.01. The specialty chemicals company earned $3.29 million during the quarter. Senomyx had a negative net margin of 9.11% and a negative return on equity of 15.80%. View Senomyx's Earnings History. Has Senomyx been receiving favorable news coverage? News coverage about SNMX stock has been trending very positive on Wednesday, according to InfoTrie Sentiment. The research group ranks the sentiment of press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Senomyx earned a coverage optimism score of 3.3 on InfoTrie's scale. They also gave headlines about the specialty chemicals company a news buzz of 2.0 out of 10, meaning that recent press coverage is very unlikely to have an effect on the stock's share price in the near future. View News Stories for Senomyx. Who are some of Senomyx's key competitors? Some companies that are related to Senomyx include STARPHARMA HOLD/S (SPHRY), Luna Innovations (LUNA), Pieris Pharmaceuticals (PIRS), Anavex Life Sciences (AVXL), Eloxx Pharmaceuticals (ELOX), Bioanalytical Systems (BASI), BIOQUAL (BIOQ), HedgePath Pharmaceuticals (HPPI), Cleveland BioLabs (CBLI), Tenax Therapeutics (TENX), Vitality Biopharma (VBIO), US Stem Cell (USRM), Protalex (PRTX), ALGAE TEC LTD/S (ALGXY) and Redpoint Bio (RPBC). What other stocks do shareholders of Senomyx own? Based on aggregate information from My MarketBeat watchlists, some companies that other Senomyx investors own include Aralez Pharmaceuticals (ARLZ), Heron Therapeutics (HRTX), Novavax (NVAX), Rexahn Pharmaceuticals (REXN), Vical (VICL), NovaBay Pharmaceuticals (NBY), Cascadian Therapeutics (CASC), DURECT (DRRX), Idera Pharmaceuticals (IDRA) and Inovio Pharmaceuticals (INO). Who are Senomyx's key executives? Senomyx's management team includes the folowing people: Mr. John W. Poyhonen, Pres, CEO & Director (Age 58)Mr. David C. Humphrey, VP & CFO (Age 49)Ms. Catherine C. Lee, Sr. VP, Gen. Counsel & Corp. Sec. (Age 44)Ms. Sharon Wicker, Sr. VP & Chief Commercial Devel. Officer (Age 62)Ms. Susan Firestone Melody, VP of HR How big of a company is Senomyx? Senomyx has a market capitalization of $0.00 and generates $29.32 million in revenue each year. The specialty chemicals company earns $-1,260,000.00 in net income (profit) each year or ($0.03) on an earnings per share basis. View Additional Information About Senomyx. What is Senomyx's official website? The official website for Senomyx is http://www.senomyx.com/. How can I contact Senomyx? Senomyx's mailing address is 4767 NEXUS CENTRE DRIVE, SAN DIEGO CA, 92121. The specialty chemicals company can be reached via phone at 858-646-8300 or via email at [email protected] MarketBeat Community Rating for Senomyx (NASDAQ SNMX)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 210 (Vote Outperform)Underperform Votes: 212 (Vote Underperform)Total Votes: 422MarketBeat's community ratings are surveys of what our community members think about Senomyx and other stocks. Vote "Outperform" if you believe SNMX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SNMX will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/29/2020 by MarketBeat.com StaffFeatured Article: Does a trade war provide a risk to the global economy?
